lobbying_activities: 3002213

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3002213	64adb652-31ba-467d-9f1d-8040ef8c8be0	Q2	MS. ERIN MOFFET	401107015	THE LIAISON GROUP ON BEHALF OF THE NATIONAL CANNABIS ROUNDTABLE	2023	second_quarter	GOV	As the federal government considers how to reconcile state legal cannabis programs with cannabis' federal illegality, the National Cannabis Roundtable supports legislation and regulatory paradigms that decriminalize cannabis, remediate the harm of the failed War on Drugs, ensure the highest standards of consumer safety, respect existing cannabis supply chains and provide equitable financial treatment for cannabis businesses. NCR also supported the reintroduction of the PREPARE Act (HR 2598), which directs federal agencies as to best practices and regulations upon federal legalization.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2023-07-13T10:11:07-04:00